tiprankstipranks
Trending News
More News >
Pharmarise Holdings Corp. (JP:2796)
:2796
Japanese Market

Pharmarise Holdings Corp. (2796) Financial Statements

Compare
0 Followers

Pharmarise Holdings Corp. Financial Overview

Pharmarise Holdings Corp.'s market cap is currently ¥6.12B. The company's EPS TTM is ¥11.37; its P/E ratio is -41.26; and it has a dividend yield of 2.65%. Pharmarise Holdings Corp. is scheduled to report earnings on December 25, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 63.51B¥ 54.47B¥ 52.03B¥ 51.61B¥ 52.32B
Gross Profit¥ 8.96B¥ 8.45B¥ 8.13B¥ 8.12B¥ 8.07B
Operating Income¥ 293.00M¥ 916.00M¥ 1.44B¥ 1.52B¥ 1.25B
EBITDA¥ 1.68B¥ 1.38B¥ 2.33B¥ 2.69B¥ 2.62B
Net Income¥ -367.00M¥ -351.00M¥ 333.00M¥ 447.00M¥ 426.00M
Balance Sheet
Cash & Short-Term Investments¥ 4.92B¥ 7.15B¥ 4.74B¥ 3.99B¥ 4.60B
Total Assets¥ 31.92B¥ 29.49B¥ 23.42B¥ 23.75B¥ 24.72B
Total Debt¥ 14.28B¥ 12.75B¥ 9.14B¥ 9.91B¥ 10.70B
Net Debt¥ 9.37B¥ 5.60B¥ 4.40B¥ 5.92B¥ 6.09B
Total Liabilities¥ 25.01B¥ 22.05B¥ 16.43B¥ 17.05B¥ 18.39B
Stockholders' Equity¥ 6.87B¥ 7.36B¥ 6.88B¥ 6.61B¥ 6.22B
Cash Flow
Free Cash Flow¥ 609.00M¥ 2.10B¥ 1.98B¥ 247.00M¥ 1.39B
Operating Cash Flow¥ 1.31B¥ 2.71B¥ 2.52B¥ 713.00M¥ 1.95B
Investing Cash Flow¥ -4.46B¥ -3.12B¥ -703.00M¥ -292.00M¥ -1.08B
Financing Cash Flow¥ 939.00M¥ 2.77B¥ -1.07B¥ -1.03B¥ -728.00M
Currency in JPY

Pharmarise Holdings Corp. Earnings and Revenue History

Pharmarise Holdings Corp. Debt to Assets

Pharmarise Holdings Corp. Cash Flow

Pharmarise Holdings Corp. Forecast EPS vs Actual EPS